The nurse's role in the assessment and treatment of bipolar disorder

Journal of the American Psychiatric Nurses Association

Volumn 9, Issue 6, 2003, Pages 180-186

  Tugrul, Karen ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLOZAPINE; LAMOTRIGINE; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; RISPERIDONE; TOPIRAMATE; VALPROIC ACID; ZIPRASIDONE;

ARTICLE; BIPOLAR DISORDER; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC ERROR; DRUG RESISTANCE; HUMAN; HYPOMANIA; LIFESTYLE; MANIA; MOOD; MORBIDITY; MORTALITY; NURSE ATTITUDE; NURSING; PATIENT EDUCATION; PREVALENCE; PSYCHOLOGIC ASSESSMENT; QUESTIONNAIRE; RECURRENT DISEASE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SUICIDE; TREATMENT OUTCOME;

EID: 1642474222     PISSN: 10783903     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.japna.2003.10.005     Document Type: Article

References (46)

1. Akiskal, H. S. (1996). The prevalent clinical spectrum of bipolar disorders: Beyond DSM-IV. Journal of Clinical Psychopharmacology, 16, 4S-14S.
2. Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Keller, M., et al. (1995). Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Archives of General Psychiatry, 52, 114-123.
3. Altman, E. G., Hedeker, D. R., Janicak, P. G., Peterson, J. L., & Davis, J. M. (1994). The Clinician-Administered Rating Scale for Mania (CARS-M): Development, reliability, and validity. Biological Psychiatry, 36, 124-134.
4. Altshuler, L., Kiriakos, L., Calcagno, J., Goodman, R., Gitlin, M., Frye, M., et al. (2001). The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of bipolar depression: A retrospective chart review. Journal of Clinical Psychiatry, 62, 612-616.
5. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text revision). Washington, DC: Author.
6. Bailey, K. (1995). The implementation of advanced practice psychiatric nurse prescribers: A comprehensive model. Journal of the American Psychiatric Nurses Association, 1, 183-189.
7. Bailey, K. (1999). Electrophysiological kindling and behavioral sensitization as models for bipolar illness. Journal of the American Psychiatric Nurses Association, 5, 62-67.
8. Bauer, M. S., Callahan, A. M., Jampala, C., Petty, F., Sajatovic, M., Schaefer, V., et al. (1999). Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs. Journal of Clinical Psychiatry, 60, 9-21.
9. Benazzi, F., & Rihmer, Z. (2000). Sensitivity and specificity of DSM-IV atypical features for bipolar II disorder diagnosis. Psychiatry Research, 93, 257-262.
10. Bowden, C. L. (2001). Strategies to reduce misdiagnosis of bipolar depression. Psychiatric Services, 52, 51-55.
11. Bowden, C. L., Calabrese, J. R., McElroy, S. L., Rhodes, L. J., Keck, P. E. Jr, Cookson, J., et al. (1999). The efficacy of lamotrigine in rapid cycling and non-rapid cycling patients with bipolar disorder. Biological Psychiatry, 45, 953-958.
12. Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., & Rudd, G. D. (1999). A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. Journal of Clinical Psychiatry, 60, 79-88.
13. Calabrese, J. R., Rapport, D. J., Kimmel, S. E., & Shelton, M. D. (1999). Controlled trials in bipolar I depression: Focus on switch rates and efficacy. European Neuropsychopharmacology, 9(Suppl. 4), S109-S112.
14. Calabrese, J. R., Rapport, D. J., Shelton, M. D., Kujawa, M., & Kimmel, S. E. (1998). Clinical studies on the use of lamotrigine in bipolar disorder. Neuropsychobiology, 38, 185-191.
15. Calabrese, J. R., Shelton, M. D., Bowden, C. L., Rapport, D. J., Suppes, T., Shirley, E. R., et al. (2001). Bipolar rapid cycling: Focus on depression as its hallmark. Journal of Clinical Psychiatry, 62(Suppl. 14), 34-41.
16. Calabrese, J. R., Woyshville, M. J., McElroy, S. L., et al. (1995). Spectrum of efficacy of lamotrigine in treatment-refractory manic depression. 2nd International Conference on New Directions in Affective Disorders.
17. Coryell, W., Endicott, J., Maser, J. D., Keller, M. B., Leon, A. C., & Akiskal, H. S. (1995). International Conference on New Directions in Affective Disorders. Long-term stability of polarity distinctions in the affective disorders. American Journal of Psychiatry, 152, 385-390.
18. Endicott, J., & Spitzer, R. L. (1978). A diagnostic interview: The schedule for affective disorders and schizophrenia. Archives of General Psychiatry, 35, 837-844.
19. Forchuk, C., Westwell, J., Martin, M. L., Bamber-Azzapardi, W., Kosterewa-Tolman, D., & Hux, M. (2000). The developing nurse-client relationship: Nurses' perspectives. Journal of the American Psychiatric Nurses Association, 6, 3-11.
20. Ghaemi, S. N., Boiman, E. E., & Goodwin, F. K. (2000). Diagnosing bipolar disorder and the effect of antidepressants: A naturalistic study. Journal of Clinical Psychiatry, 61, 804-808.
21. Ghaemi, S. N., Lenox, M. S., & Baldessarini, R. J. (2001). Effectiveness and safety of long-term antidepressant treatment in bipolar disorder. Journal of Clinical Psychiatry, 62, 565-569.
22. Ghaemi, S. N., Sachs, G. S., Chiou, A. M., Pandurangi, A. K., & Goodwin, K. (1999). Is bipolar disorder still underdiagnosed? Are antidepressants overutilized? Journal of Affective Disorders, 52, 135-144.
23. Goldberg, J. F., Harrow, M., & Whiteside, J. E. (2001). Risk for bipolar illness in patients initially hospitalized for unipolar depression. American Journal of Psychiatry, 158, 1265-1270.
24. Goodwin, F. K., Jamison, K. R. (1990). Suicide. In Manic-depressive illness (pp. 227-246). New York: Oxford University Press.
25. Hantouche, E. G., Akiskal, H. S., Lancrenon, S., Allilaire, J. F., Sechter, D., Azorin, J. M., et al. (1998). Systematic clinical methodology for validating bipolar-II disorder: Data in mid-stream from a French national multi-site study (EPIDEP). Journal of Affective Disorders, 50, 163-173.
26. Hirschfeld, R. M. A., Bowden, C. L., Perlis, R. H., Gitlin, M. J., Suppes, T., Keck, P. E., et al. (2002). Practice guideline for the treatment of patients with bipolar disorder (revision). American Journal of Psychiatry, 159, 1-50.
27. Hirschfeld, R. M., Williams, J. B., Spitzer, R. L., Calabrese, J. R., Flynn, L., Keck, P. E. Jr, et al. (2000). Development and validation of a screening instrument for bipolar spectrum disorder: The Mood Disorder Questionnaire. American Journal of Psychiatry, 157, 1873-1875.
28. Hoopes, S. P. (1998). Lamotrigine in the treatment of affective disorders: A clinical experience. European Neuropsychopharmacology, 8, S138-S139.
29. Hovey, J., & McEnany, G. (1996). Psychobiologic knowledge and prescriptive authority: RX for change in nursing practice. Journal of the American Psychiatric Nurses Association, 2, 164-166.
30. IMS America. (1998). National disease and therapeutic index. Fairfield, CT: IMS Health.
31. Jamison, K. R. (2000). Suicide and bipolar disorder. Journal of Clinical Psychiatry, 61(Suppl. 9), 47-51.
32. Kukopulos, A., Reginaldi, D., Laddomada, P., Floris, G., Serra, G., & Tondo, L. (1980). Course of the manic-depressive cycle and changes caused by treatment. Pharmakopsychiatrie, Neuro-Psychopharmakologie, 13, 156-167.
33. Ling, Y. H., Liebes, L., Ng, B., Buckley, M., Elliott, P. J., Adams, J., et al. (2002). PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis. Molecular Cancer Therapeutics, 1, 841-849.
34. Manning, J. S., Connor, P. D., & Sahai, A. (1998). The bipolar spectrum: A review of current concepts and implications for the management of depression in primary care. Archives of Family Medicine, 7, 63-71.
35. Manning, J. S., Haykal, R. F., Connor, P. D., & Akiskal, H. S. (1997). On the nature of depressive and anxious states in a family practice setting: The high prevalence of bipolar II and related disorders in a cohort followed longitudinally. Comprehensive Psychiatry, 38, 102-108.
36. Miklowitz, D. J., & Frank, E. (1999). New psychotherapies for bipolar disorder: In J. F. Goldberg, M. Harrow (Eds.), Bipolar disorders: Clinical course and outcome pp. 57-84. Washington, DC: American Psychiatric Press.
37. Mitchell, P., Parker, G., Jamieson, K., Wilhelm, K., Hickie, I., Brodaty, H., et al. (1992). Are there any differences between bipolar and unipolar melancholia? Journal of Affective Disorders, 25, 97-105.
38. Muller-Oerlinghausen, B., Retzow, A., Henn, F. A., Giedke, H., & Walden, J. (2000). Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: A prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group. Journal of Clinical Psychopharmacology, 20, 195-203.
39. National Institutes of Health. (1995). Bipolar disorder. NIH Publication No.95-3679. Washington, DC: Author.
40. Sachs, G. S., Printz, D. J., Kahn, D. A., Carpenter, D., Docherty, J. P. (2000). The expert consensus guidelines series: Medication treatment of bipolar disorder 2000. Postgraduate Medicine, Spec No, 1-104.
41. Shea, N., McBride, L., Gavin, C., & Bauer, M. (1997). The effects of an ambulatory collaborative practice model on process and outcome of care for bipolar disorder. Journal of the American Psychiatric Nurses Association, 3, 49-58.
42. Suppes, T., Brown, E. S., McElroy, S. L., Keck, P. E. Jr, Nolen, W., Kupka, R., et al. (1999). Lamotrigine for the treatment of bipolar disorder: A clinical case series. Journal of Affective Disorders, 53, 95-98.
43. Suppes, T., Leverich, G. S., Keck, P. E., Nolen, W. A., Denicoff, K. D., Altshuler, L. L., et al. (2001). The Stanley Foundation Bipolar Treatment Outcome Network. II. Demographics and illness characteristics of the first 261 patients. Journal of Affective Disorders, 67, 45-59.
44. Swann, A. C., Bowden, C. L., Calabrese, J. R., Dilsaver, S. C., & Morris, D. D. (1999). Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. American Journal of Psychiatry, 156, 1264-1266.
45. Winokur, G., Coryell, W., Endicott, J., & Akiskal, H. (1993). Further distinctions between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression). American Journal of Psychiatry, 150, 1176-1181.
46. Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978). A rating scale for mania: Reliability, validity and sensitivity. British Journal of Psychiatry, 133, 429-435.